What we still don’t know about weight-loss drugs
Weight-loss drugs have been back in the news this week. First, we heard that Eli Lilly, the company behind the
Read MoreWeight-loss drugs have been back in the news this week. First, we heard that Eli Lilly, the company behind the
Read MoreIf we didn’t have pictures and videos, I almost wouldn’t believe the imagery that came out of this year’s UN
Read MoreSeparating AI reality from hyped-up fiction isn’t always easy. That’s why we’ve created the AI Hype Index—a simple, at-a-glance summary
Read MoreWelcome back to The State of AI, a new collaboration between the Financial Times and MIT Technology Review. Every Monday,
Read MoreIn 2017, fresh off a PhD on theoretical chemistry, John Jumper heard rumors that Google DeepMind had moved on from
Read MoreIt has started to get really wintry here in London over the last few days. The mornings are frosty, the
Read MoreOne of the dominant storylines I’ve been following through 2025 is electricity—where and how demand is going up, how much
Read MoreA group of quantum physicists claims to have created a version of the powerful reasoning AI model DeepSeek R1 that
Read MoreGoogle today unveiled Gemini 3, a major upgrade to its flagship multimodal model. The firm says the new model is
Read More